Ion Exchange (India) Ltd Q1 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/pqmpyd00xm4r0fnve0u1qs4d.pdf

# 1. Financial Performance

## A. Key Figures
   * Operating Income: ₹583.2 Cr consolidated (+3%)
   * EBITDA: ₹627 Mn consolidated (-2%) · EBITDA Margin: 10.75%
   * Net Profit: **₹484 Mn** (+8%) · **PAT Margin:** **~8.3%**
   *   **Other Income:** **₹19 Cr** (FD interest, forex gains)

## B. Margins & Profitability
   *   **Margin Volatility:** Q1 FY26 margins benefited from a **one-time event**, with underlying performance below prior year’s closing rate.
   *   **Order Book Quality:** Excluding adverse order, expected margins on backlog are in line with standard EPC margin profile for FY24-25.
   *   **Cost Discipline:** Rising employee costs from annual escalations partially offset by productivity initiatives.

## C. Cash Flow & Income
   *   **Non-Operating Support:** Strong other income driven by **₹19 Cr** in interest and forex gains, boosting bottom line despite EBITDA decline.

---

# 2. Order Book & Inquiries

## A. Key Figures
   *   **Order Book:** **₹2,664 Cr** (as of end-Q1 FY)
   *   **Bid Pipeline:** **>₹9,200 Cr** (as of end-Q1 FY)
   *   **UP Project EPC Backlog:** **₹366 Cr** outstanding

## B. Order Inflow Timing
   *   **Delayed Bid Outcomes:** No major order wins in the quarter due to **timing delays** in high-value engineering project awards, despite active pursuit of domestic and international opportunities.
   *   **No Order Losses:** Management confirms **no adverse losses** in the quarter, with confidence that pending bids will resolve over time.

## C. Bid Pipeline Value
   *   **Robust Pipeline Visibility:** Despite near-term uncertainty in order conversion, a **strong bid pipeline exceeding ₹9,200 Cr** supports medium-term revenue visibility.
   *   **Selective Order Strategy:** Focus remains on accretive opportunities that maintain or enhance segment profitability, reflecting disciplined capital allocation.

## D. Backlog Adjustments
   *   **UP Jal Nigam Adjustment:** Partial removal of contracts from backlog due to slow execution, contributing to reported decline since prior quarter.
   *   **Adverse Order Timeline Update:** Previously disclosed challenging project now expected to be **fully executed by end of current FY**, later than earlier projected timeline.
   *   **O&M Value Pending:** O&M component for UP project not included in backlog; quantification deferred until commissioning progress clarifies final scope and value.

---

# 3. Segment Performance

## A. Key Figures
   * Engineering Revenue: ₹3180 Mn (-2%) · EBIT: ₹278 Mn (+48%)
   * Chemical Revenue: ₹1,889 Mn (-5%) · EBIT: ₹467 Mn (-6%)
   * Consumer Products Revenue: ₹902 Mn (+36%) · Loss: ₹9 Mn (vs. ₹34 Mn loss YoY)

## B. Engineering Division
   *   **Profitability Surge Driven by One-Time Gain:** EBIT margin reached a 4–5 quarter high of **7%**, significantly boosted by a **one-time cost rebate** from a large EPC contract.
   *   **Underlying Margins Weaker:** Excluding the rebate, profitability declined YoY due to **elevated infrastructure costs** and underutilization from lower revenue.
   *   **Order Inflow Pressured by Project Delays:** Inquiry pipeline remains stable, but large project finalizations and muted execution (e.g., UP Jal Nigam) constrained backlog growth.
   *   **Strategic Technology Expansion:** In-house ultra-pure water systems—evolved from INDION Swift 5Gx—now target high-growth sectors including **semiconductors, solar, and data centers**, with active project execution in solar.
   *   **Selective Bidding Discipline:** Focus remains on profitable industrial projects; semiconductor and solar module opportunities pursued selectively due to project heterogeneity.

## C. Chemical Division
   *   **Stabilized Profitability After Inflation Shock:** Segment returned to prior-year average margins despite slight YoY revenue and EBIT decline, recovering from RM cost pressures in Q4.
   *   **Cautious Outlook Amid Input Volatility:** Q1 performance positive, but ongoing monitoring required for input costs and potential **depreciation impacts** on margins.

## D. Consumer Products
   *   **Strong Top-Line Momentum, Widening Losses:** Revenue growth reflects **deeper market penetration** and **shorter-cycle demand strength**, though losses widened due to continued investments.
   *   **Scale Still Below Breakeven Threshold:** Despite growth, segment remains loss-making with **revenue below the ₹500 Cr breakeven target**, currently at over ₹300 Cr run-rate.
   *   **Multi-Channel Expansion Underway:** Company is scaling presence across **residential, commercial, institutional, and rural markets**, supported by new product launches like **alkaline and hydrogen water systems**.
   *   **Investment Intensity High in Competitive Landscape:** Sustained innovation, production tech upgrades, and **cost competitiveness** are critical to defend and grow share.

---

# 4. Capacity & Operations

## A. Key Figures
   *   **Revenue Impact:** **Single-digit percentage** range due to SAP transition
   *   **CAPEX (Roha Plant):** **₹400 Cr** (₹275 Cr manufacturing base + ₹125 Cr cost optimization)
   * **Asset Turnover (Roha):** **2.5x** expected
   *   **Roha Revenue Target:** **₹1,000 Cr** by FY28

## B. SAP Transition Impact
   *   **Significant but Contained Disruption:** SAP migration caused a single-digit percentage revenue loss, with the chemical segment fully offline in April due to its consumable-driven model and limited recovery potential.
   *   **Operations Stabilized:** Business has largely returned to normal across all chemical plants as of July, with engineering revenue timing impacts expected to recover within the current and next quarter.
   *   **De-growth Not Strategic:** Decline in chemical segment volumes was purely transitional, not driven by margin protection or demand weakness.

## C. Roha Plant Commissioning
   *   **On Track for Q2 FY26 Commissioning:** Roha greenfield resin plant remains on schedule, with product stabilization and quality assurance in progress; shipping expected by quarter-end.
   *   **Phased Ramp-Up with Export Focus:** Full capacity to be reached in under four years, leveraging modern systems to support expansion in Americas, Europe, Asia-Pacific, and Middle East.
   *   **High Return Expectations:** Management projects ₹1,000 Cr revenue by FY28 on a ₹400 Cr CAPEX outlay, underpinned by a targeted 5x asset turnover.

## D. Utilization Rates
   *   **Current Utilization at 65%:** Chemical plant capacity utilization remains below potential due to SAP-related volume suppression, but significant upside is expected as operations normalize.
   *   **Flexible Expansion Plans:** Membrane component capacity will be scaled incrementally in line with demand, ensuring alignment with utilization trends.

---

# 5. Export & Geography Mix

## A. International Markets
   *   **Headline:** New 25% tariffs on Indian exports pose potential headwinds; management assessing impact despite no prior disruption to US sales.
   *   **Headline:** Competitive dynamics in Europe and India reshaped by **15% and 25% tariff rates**, affecting positioning against Ecolab and Lantis.
   *   **Headline:** Strategic focus on **profit-accretive EPC orders** in high-growth regions, with active pursuit of **large international contracts** expected within nine months.
   *   **Headline:** Expansion momentum in **Nepal and Middle East**, driven by demand for desalination infrastructure and engineering capabilities.
   *   **Headline:** Roha plant primarily dedicated to serving **export markets** (USA, Europe, APAC, Middle East), underscoring global supply footprint.

## B. US Growth Strategy
   *   **Headline:** US targeted as key growth frontier, with plans to scale presence comparable to established footprint in Europe and APAC.
   *   **Headline:** Competitive challenges persist from **European manufacturers** with integrated chemical offerings, potentially constraining volume gains.
   *   **Headline:** Management maintains that current product lines remain **unaffected by existing tariffs**, though recent increases under evaluation.

## C. Regional Expansion
   *   **Headline:** **Pharma, solar, and semiconductor** segments now core to business, reflecting successful diversification into sunrise industries.

---

# 6. Risks & Project Execution

## A. UP Funding Delays
   *   **Adequate Provisioning:** Management confirms **₹2 Cr** provision in FY '24 is sufficient to cover potential credit losses across challenging projects, including UP.
   *   **Execution Headwinds:** UP project remains onerous with **slow execution and elevated receivables** due to persistent funding constraints from the state government.
   *   **Near-Term Drag:** Funding delays are expected to persist through current FY, limiting profitability improvement; **no cost escalation pass-through allowed** under existing contracts.
   *   **Active Engagement:** Company is in ongoing discussions with Uttar Pradesh government and remains cautiously optimistic about future fund allocation enabling receivables liquidation.

## B. Monsoon Disruptions
   *   **Seasonal Impact:** Outdoor construction in India is temporarily affected by monsoon conditions, though indoor and international project work continues unaffected.

## C. Legacy Project Exposure
   *   **Reduced Drag:** Legacy projects, which pressured margins last year, had **minimal impact this quarter**, supporting YoY margin recovery.
   *   **Closure Timeline:** While UP project extends into next fiscal, **legacy work is on track to substantially close by current FY-end**.
   *   **Selective Bidding:** Amid intense domestic competition and pricing pressure, company maintains disciplined project selection to protect margins.

---

# 7. Guidance & Outlook

## A. Revenue Recovery
   *   **Cautious Stance on Engineering Division:** No full-year growth guidance to be provided until after Q2; current outlook unchanged from prior quarter.
   *   **Stable-to-Gradual Improvement in Consumer Products:** Management sees further upside potential long-term but aims only to maintain current performance levels this year.

## B. Profitability Expectations
   *   **Engineering Margins Under Pressure:** Current high margins are not sustainable—would have been below prior-year levels excluding one-time benefit.
   *   **Limited Segment Profitability Improvement Expected:** Overall profitability unlikely to see meaningful expansion in FY.
   *   **Product Segment Path to Breakeven:** Margins expected to improve year-on-year with potential for lower losses, contingent on achieving **Rs.500 crore revenue threshold**.